MLSS Share Price | Milestone Scientific, Inc. Stock Analysis & Recommendation

Q: How big is Milestone Scientific, Inc.?

Market Cap: As of Jun 18, Milestone Scientific, Inc. has a market capitalization of 67.91 million, categorizing it as a Micro Cap company.Recent Quarterly Performance: For the latest four quarters ending in March 2025, the company reported net sales of 8.60 million. During the same period, the consolidated net profit was a loss of 5.27 million.Balance Sheet Snapshot: As of December 2024, the shareholder's funds amounted to 5.83 million, while total assets were reported at 9.80 million.

Q: What does Milestone Scientific, Inc. do?

Overview: Milestone Scientific, Inc. is engaged in providing computer-controlled injection technologies and solutions for the medical and dental markets within the Pharmaceuticals & Biotechnology industry, classified as a micro-cap company.Financial Snapshot: Most recent Net Sales: 2 Million (Quarterly Results - Mar 2025) Most recent Net Profit: -2 Million (Quarterly Results - Mar 2025) Market-cap: USD 67.91 Million (Micro Cap)Key Metrics: P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 0.00% Debt Equity: -0.47 Return on Equity: -118.04% Price to Book: 15.22Contact Details: Address: 220 S Orange Ave, LIVINGSTON NJ: 07039-5804 Tel: 1 973 5352717 Fax: 1 973 5352829 Website: https://www.milestonescientific.com/

Q: Is Milestone Scientific, Inc. technically bullish or bearish?

As of 10 September 2025, the technical trend for Milestone Scientific, Inc. has changed from mildly bearish to bearish. The current stance is bearish with weak strength, indicated by the daily moving averages and the weekly KST and OBV both showing bearish signals. The MACD is mildly bullish on the weekly but bearish on the monthly, which adds to the mixed signals. The Bollinger Bands are bearish on both weekly and monthly time frames. In terms of performance, the stock has significantly underperformed compared to the S&P 500 across multiple periods, with a year-to-date return of -43.98% versus the S&P 500's 12.22%, and a 1-year return of -40.02% compared to 17.14% for the index.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

12.25 k

Shareholding (Sep 2025)

FII

0.15%

Held by 8 FIIs

DII

96.01%

Held by 4 DIIs

Promoter

0.00%

How big is Milestone Scientific, Inc.?

22-Jun-2025

As of Jun 18, Milestone Scientific, Inc. has a market capitalization of 67.91 million, with recent net sales of 8.60 million and a net loss of 5.27 million for the four quarters ending in March 2025. As of December 2024, shareholder's funds were 5.83 million, and total assets were 9.80 million.

View full answer

What does Milestone Scientific, Inc. do?

22-Jun-2025

Milestone Scientific, Inc. develops computer-controlled injection technologies for the medical and dental sectors, operating as a micro-cap company with a market cap of approximately $67.91 million. As of March 2025, it reported net sales of $2 million and a net loss of $2 million.

View full answer

Who are in the management team of Milestone Scientific, Inc.?

22-Jun-2025

As of March 2022, the management team of Milestone Scientific, Inc. includes Ms. Leslie Bernhard (Independent Non-Executive Chairman), Mr. Leonard Osser (Director), Mr. Gian Trombetta (Director), Mr. Neal Goldman (Independent Director), and Mr. Michael McGeehan (Independent Director). They are responsible for the company's strategic direction and governance.

View full answer

Is Milestone Scientific, Inc. technically bullish or bearish?

20-Sep-2025

As of September 10, 2025, Milestone Scientific, Inc. is in a bearish trend with weak strength, indicated by bearish signals from daily moving averages, weekly KST, and OBV, while significantly underperforming the S&P 500 with year-to-date and 1-year returns of -43.98% and -40.02%, respectively.

View full answer

Compare Milestone Scientific, Inc. with Similar Stocks

Prenetics Global Ltd.CollPlant Biotechnologies Ltd.Beyond Air, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 21 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.15

Return on Equity

-261.52%

Price to Book

8.18

Revenue and Profits:

Net Sales:

2 Million

(Quarterly Results - Jun 2025)

Net Profit:

-1 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-38.45%

6 Months

-51.8%

1 Year

-80.23%

2 Years

-58.19%

3 Years

-63.71%

4 Years

-79.1%

5 Years

-92.2%

Milestone Scientific, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

8.00%

EBIT Growth (5y)

-0.41%

EBIT to Interest (avg)

-7.58

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.47

Sales to Capital Employed (avg)

1.53

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

6.59%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

16.05

EV to EBIT

-9.54

EV to EBITDA

-9.73

EV to Capital Employed

29.55

EV to Sales

8.07

PEG Ratio

Dividend Yield

ROCE (Latest)

-309.83%

ROE (Latest)

-118.04%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

Mildly Bullish

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Sep 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 4 Schemes (3.85%)

Foreign Institutions

Held by 8 Foreign Institutions (0.15%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 4.55% vs 10.00% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 25.00% vs 0.00% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2.30",
          "val2": "2.20",
          "chgp": "4.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.40",
          "val2": "-2.00",
          "chgp": "30.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.50",
          "val2": "-2.00",
          "chgp": "25.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-639.00%",
          "val2": "-894.90%",
          "chgp": "25.59%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -12.24% vs 11.36% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 32.86% vs 20.45% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "8.60",
          "val2": "9.80",
          "chgp": "-12.24%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-6.60",
          "val2": "-7.00",
          "chgp": "5.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-4.70",
          "val2": "-7.00",
          "chgp": "32.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-783.00%",
          "val2": "-723.10%",
          "chgp": "-5.99%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

2.30

2.20

4.55%

Operating Profit (PBDIT) excl Other Income

-1.40

-2.00

30.00%

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

-1.50

-2.00

25.00%

Operating Profit Margin (Excl OI)

-639.00%

-894.90%

25.59%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is 4.55% vs 10.00% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 25.00% vs 0.00% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

8.60

9.80

-12.24%

Operating Profit (PBDIT) excl Other Income

-6.60

-7.00

5.71%

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

-4.70

-7.00

32.86%

Operating Profit Margin (Excl OI)

-783.00%

-723.10%

-5.99%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is -12.24% vs 11.36% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 32.86% vs 20.45% in Dec 2023

All Annual Results

Company CV

About Milestone Scientific, Inc.

Milestone Scientific, Inc.

Pharmaceuticals & Biotechnology

Milestone Scientific Inc. (Milestone) is engaged in providing computer-controlled injection technologies and solutions for the medical and dental markets. The Company uses its CompuFlo technology for the delivery of medicaments. The CompuFlo pressure or force Computer-Controlled Local Anesthetic Delivery (C-CLAD) technology is a medical technology for the delivery of drugs, anesthetics and other medicaments into various tissue types. Milestone's product portfolio includes Single Tooth Anesthesia Instrument (STA Instrument), CompuDent, CompuMed and The Wand. The Company's STA Instrument is a computer-controlled local anesthesia delivery instrument that utilizes the pressure feedback elements of Milestone's CompuFlo technology. CompuDent (also known as the Wand Plus internationally) is Milestone's C-CLAD instrument. CompuMed is a computer-controlled injection instrument offered by the Company. The Wand handpiece is used in conjunction with the STA, CompuDent and CompuMed instruments.

Company Coordinates

Company Details

220 S Orange Ave , LIVINGSTON NJ : 07039-5804

Tel: 1 973 5352717

https://www.milestonescientific.com/

Registrar Details

Milestone Scientific, Inc.

1Day

52 Week

CASH

FII

DII

Promoter

How big is Milestone Scientific, Inc.?

Watch in Real-Time

What does Milestone Scientific, Inc. do?

Who are in the management team of Milestone Scientific, Inc.?

Is Milestone Scientific, Inc. technically bullish or bearish?

Compare Milestone Scientific, Inc. with Similar Stocks

MarketsMojo — Loved in India, Now Global

Dashboard

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Sep 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Annual Results Snapshot (Consolidated) - Dec'24

About Milestone Scientific, Inc.

Company Coordinates